Subscribe
Rolf Dannenberg / Shutterstock.com
8 July 2025NewsAmericasLiz Hockley

UKIPO rejects Boehringer’s SPC for horse inhaler

Office declined application, citing earlier authorisations for inhalers designed for people  containing the same ingredient  | Boehringer argued that ciclesonide was a ‘new active substance’ not previously authorised for a veterinary product in the EU.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Sanofi successfully challenges rare disease patent in Europe
1 July 2025   French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient disclosure of antibody production | Appeal focused on detection method claims and biomarker specificity.
Europe
UK govt sets sights on being AI drug discovery ‘world leader’
13 June 2025   Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.
Europe
‘Keep calm and carry on’: UK+ regime stays post-Brexit
27 May 2025   With the regime affecting UK exports to the EEA set to continue, Charlotte Peach of Taylor Wessing explores some of the practical implications for businesses.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Europe
Sanofi successfully challenges rare disease patent in Europe
1 July 2025   French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient disclosure of antibody production | Appeal focused on detection method claims and biomarker specificity.
Europe
UK govt sets sights on being AI drug discovery ‘world leader’
13 June 2025   Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.
Europe
‘Keep calm and carry on’: UK+ regime stays post-Brexit
27 May 2025   With the regime affecting UK exports to the EEA set to continue, Charlotte Peach of Taylor Wessing explores some of the practical implications for businesses.

More on this story

Europe
Sanofi successfully challenges rare disease patent in Europe
1 July 2025   French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient disclosure of antibody production | Appeal focused on detection method claims and biomarker specificity.
Europe
UK govt sets sights on being AI drug discovery ‘world leader’
13 June 2025   Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.
Europe
‘Keep calm and carry on’: UK+ regime stays post-Brexit
27 May 2025   With the regime affecting UK exports to the EEA set to continue, Charlotte Peach of Taylor Wessing explores some of the practical implications for businesses.

More features

WilmerHale gains partner with ‘deep expertise’
Bayer, Orion take on Indian generic over $117bn drug
‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe